Announcements Trials

Browse Landscape

Phase

Status

Recruiting 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 21 Neoplasm Metastasis 8 Lung Neoplasms 7 Squamous Cell Carcinoma of Head and Neck 6 Neoplasms 6 Ovarian Neoplasms 5 Melanoma 5 Carcinoma, Renal Cell 5 Skin Neoplasms 4 Fallopian Tube Neoplasms 4 Carcinoma 4 Triple Negative Breast Neoplasms 3 Recurrence 3 Prostatic Neoplasms 3 Mouth Neoplasms 3 Colorectal Neoplasms 3 Breast Neoplasms 3 Adenocarcinoma 3 Uveal Melanoma 2 Uterine Cervical Neoplasms 2 Urinary Bladder Neoplasms 2 Sarcoma 2 Pancreatic Neoplasms 2 Mycosis Fungoides 2 Multiple Myeloma 2 Lymphoma, T-Cell 2 Lymphoma, Large-Cell, Anaplastic 2 Laryngeal Neoplasms 2 Head and Neck Neoplasms 2 Endometrial Neoplasms 2

Interventions

Capecitabine 29 Oxaliplatin 28 Fluorouracil 16 Radiotherapy 15 Drug Therapy 11 Leucovorin 10 Bevacizumab 10 Surgical Procedures, Operative 9 Chemoradiotherapy 8 Radiation 7 sintilimab 6 Consolidation Chemotherapy 6 tislelizumab 5 spartalizumab 5 Specimen Handling 5 Irinotecan 5 Folfox protocol 5 trifluridine tipiracil drug combination 4 XELOX 4 Neoadjuvant Therapy 4 Endoscopy 4 Cetuximab 4 Biopsy 4 toripalimab 3 pembrolizumab 3 irinotecan sucrosofate 3 X-Rays 3 Radiotherapy, Intensity-Modulated 3 Proctectomy 3 Mastectomy, Segmental 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Rectal Neoplasms × cemiplimab × Clear all

NCT07433673 2026-02-25

GAP Cemi

Columbia University

Phase 2 Recruiting

Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡